These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19906032)

  • 1. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient.
    Zanone MM; Favaro E; Quadri R; Miceli I; Giaretta F; Romagnoli R; David E; Perin PC; Salizzoni M; Camussi G
    Transpl Int; 2010 Mar; 23(3):333-7. PubMed ID: 19906032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation.
    Petruzzo P; Andreelli F; McGregor B; Lefrançois N; Dawahra M; Feitosa LC; Dubernard JM; Thivolet C; Martin X
    Diabetes Metab; 2000 May; 26(3):215-8. PubMed ID: 10880896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
    Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
    Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.
    Sibley RK; Sutherland DE; Goetz F; Michael AF
    Lab Invest; 1985 Aug; 53(2):132-44. PubMed ID: 3894793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation.
    Jaeger C; Brendel MD; Eckhard M; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2000; 108(5):328-33. PubMed ID: 10989950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.
    Jang HJ; Kim SC; Cho YP; Kim YH; Han MS; Han DJ
    Transplant Proc; 2004 Sep; 36(7):2200-2. PubMed ID: 15518799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant type 1 diabetes in Australia in the absence of humoral and cellular immune responses to pancreatic islet autoantigens.
    Lee I; Harrison LC; Colman PG
    Diabetes Res Clin Pract; 2012 Jan; 95(1):e4-6. PubMed ID: 22014766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
    Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
    J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?
    Mojtahedi Z; Farjadian S; Ghaderi A
    Med Hypotheses; 2005; 64(5):986-8. PubMed ID: 15780496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.